PrevCardioOncAI: Machine Learning Algorithms for Predicting Cardiovascular Disease in Cancer Survivors
Journal of the American Heart Association · 2025
DOI: 10.1161/jaha.123.030363 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, 2025. Verfasst von Sherry-Ann Brown und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine Medical College of Wisconsin Milwaukee WI USA. Hauptthemen laut MEDLINE: Algorithms, Cancer Survivors, Cardiovascular Diseases, Machine Learning. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NCATS NIH HHS.
Abstract (Originalsprache)
Background
Cardiovascular disease (CVD) is a leading cause of death in cancer survivors. Predicting CVD risk in this population remains challenging. Risk prediction models that use machine learning algorithms could provide an objective method for accurate risk prediction to facilitate the prevention and management of CVD in cancer survivors. We evaluated previously tested machine learning algorithms and logistic regression (regularized by machine learning methods), in addition to testing and validating newer, more complex machine learning algorithms, for CVD prediction in cancer survivors.
Methods
This multicenter study used a database of 3835 multiracial cancer survivors with 89 clinical, laboratory, and echocardiographic features over 20 years. Models were trained using repeated random and time‐split samples and tested on a separate cohort of 329 patients. Model performance was assessed using the area under the receiver operating characteristic curve.
Results
Regularized logistic regression achieved an area under the receiver operating characteristic curve of 0.845 (heart failure), 0.783 (atrial fibrillation), 0.792 (coronary artery disease), and 0.806 (composite CVD). These are comparable to 0.837 and 0.848 for heart failure, using Bayesian additive regression tree and random forest as more advanced machine learning models, respectively. De novo composite CVD (post‐cancer diagnosis) was also predicted with an area under the receiver operating characteristic curve of 0.826 using regularized logistic regression, compared with 0.735 and 0.802 using decision tree and random forest, respectively.
Conclusions
Regularized logistic regression and advanced machine learning models demonstrated similar predictive performance, with institutional transferability. These tools may support risk stratification and prevention strategies in cardio‐oncology using longitudinal data. Registration URL: https://www.clinicaltrials.gov ; Unique identifier: NCT05377320.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medicine Medical College of Wisconsin Milwaukee WI USA.
- Department of Cardiovascular Medicine Mayo Clinic Rochester MN USA.
- Heart Innovation and Equity Research (HIER) Institute Miami FL USA.
- Cleveland Clinic Lerner College of Medicine, Case Western Reserve University Cleveland OH USA.
- Institute for Health and Equity, Medical College of Wisconsin Milwaukee WI USA.
- Genomic Medicine Institute Lerner Research Institute, Cleveland Clinic Cleveland OH USA.
ORCID-Profile: Sherry-Ann Brown, Michelle Z Fang, Rodney Sparapani, Kristen Osinski, Bradley Taylor, Rushabh Shah, Patrick Collier, Mehri BagheriMohamadiPour, Anai Kothari, Gift Echefu, John Rickards, Jessica Olson, Yee Chung Cheng, Feixiong Cheng
Förderung
- NHLBI NIH HHS
- NCATS NIH HHS
Zitieren
APA
Brown, S. A., Fang, M. Z., Sparapani, R., Zhou, Y., Osinski, K., Taylor, B., Yu, D., Blessing, J., Shah, R., Collier, P., BagheriMohamadiPour, M., Zhang, J., Kothari, A., Echefu, G., Rickards, J., Otto, C., Sanchez, Z., Olson, J., Arruda-Olson, A., …, & Cardio‐Oncology Artificial Intelligence Informatics and Precision Equity, and Patient Similarity Algorithms in the Prevention of Cardiovascular Toxicity Resear… (2025). PrevCardioOncAI: Machine Learning Algorithms for Predicting Cardiovascular Disease in Cancer Survivors. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.030363
Vancouver
Brown SA, Fang MZ, Sparapani R, Zhou Y, Osinski K, Taylor B, et al. PrevCardioOncAI: Machine Learning Algorithms for Predicting Cardiovascular Disease in Cancer Survivors. Journal of the American Heart Association. 2025. doi:10.1161/jaha.123.030363
BibTeX
@article{Brown2025,
author = {Brown, Sherry-Ann and Fang, Michelle Z and Sparapani, Rodney and Zhou, Yadi and Osinski, Kristen and Taylor, Bradley and Yu, Duo and Blessing, Jeffrey and Shah, Rushabh and Collier, Patrick and BagheriMohamadiPour, Mehri and Zhang, Jun and Kothari, Anai and Echefu, Gift and Rickards, John and Otto, Cameron and Sanchez, Zanele and Olson, Jessica and Arruda-Olson, Adelaide and Cheng, Yee Chung and Cheng, Feixiong and Cardio‐Oncology Artificial Intelligence Informatics and Precision Equity, and Patient Similarity Algorithms in the Prevention of Cardiovascular Toxicity Resear…, Cardio‐Oncology Artificial Intelligence Informatics and Precision Equity, and Patient Similarity Algorithms in the Prevention of Cardiovascular Toxicity Resear…},
title = {PrevCardioOncAI: Machine Learning Algorithms for Predicting Cardiovascular Disease in Cancer Survivors},
journal = {Journal of the American Heart Association},
year = {2025},
doi = {10.1161/jaha.123.030363}
}
EUVIMED